parecoxib has been researched along with Cardiac Remodeling, Ventricular in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbate, A; Hoke, NN; Houser, JE; Ownby, ED; Salloum, FN; Seropian, IM; Van Tassell, BW; Varma, A | 1 |
| Abbate, A; Baldi, A; Biasucci, LM; Biondi-Zoccai, GG; Capogrossi, MC; Crea, F; Das, A; Kukreja, RC; Mellone, P; Ockaili, RA; Piro, M; Qureshi, IZ; Salloum, FN; Severino, A; Straino, S; Vetrovec, GW | 1 |
2 other study(ies) available for parecoxib and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Parecoxib inhibits apoptosis in acute myocardial infarction due to permanent coronary ligation but not due to ischemia-reperfusion.
Topics: Acute Disease; Animals; Apoptosis; Coronary Stenosis; Coronary Vessels; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Echocardiography; Injections, Intraperitoneal; Isoxazoles; Ligation; Male; Mice; Myocardial Infarction; Myocardial Reperfusion Injury; Myocardium; Ventricular Remodeling | 2009 |
Protective effects of parecoxib, a cyclo-oxygenase-2 inhibitor, in postinfarction remodeling in the rat.
Topics: Animals; Apoptosis; Arterioles; Cyclooxygenase 2 Inhibitors; Cytokines; Echocardiography; Heart; Isoxazoles; Male; Myocardial Infarction; Myocardium; Organ Size; Rats; Rats, Wistar; Survival Analysis; Ventricular Remodeling | 2007 |